Gradel Kim O, Schønheyder Henrik C, Dethlefsen Claus, Kristensen Brian, Ejlertsen Tove, Nielsen Henrik
Department of Infectious Diseases, Medicinerhuset, Mølleparkvej 4, Aalborg Hospital, Aarhus University Hospital, 9000 Aalborg, Denmark.
J Infect. 2008 Sep;57(3):214-22. doi: 10.1016/j.jinf.2008.06.013. Epub 2008 Jul 25.
To evaluate the impact of age and comorbidity on the risk and prognosis of zoonotic Salmonella and Campylobacter gastroenteritis in elderly individuals.
Registry-based study comprising all first-time zoonotic Salmonella/Campylobacter gastroenteritis infections in two Danish counties from 1991 through 2003. Cases were elderly (>or=65 years) Salmonella/Campylobacter patients. Younger Salmonella/Campylobacter patients and age and gender matched individuals were reference persons.
There were 13,324 Salmonella/Campylobacter patients (including 1226 elderly patients) and 26,648 matched reference persons. Elderly Salmonella/Campylobacter patients had more comorbidity than their matched reference persons (OR [95% CI]: 1.56 [1.35-1.80]) and comorbidity adjusted mortality rate ratios (95% CI) were 11.4 (5.1-25.4), 1.9 (1.4-2.6), and 1.3 (0.9-1.9) at day 0-30, 31-180, and 181-365, respectively. The differences in crude 365-day mortality increased with age when Salmonella/Campylobacter patients and reference persons without comorbidity were compared. The independent impact of age was less clear for individuals with comorbidity. There were no differences in comorbidity or survival between non-hospitalized elderly patients and their matched reference persons.
Elderly hospitalized Salmonella/Campylobacter patients had higher comorbidity and 1-year mortality than the background population. The excess 30-day mortality elucidated the prognostic role of the Salmonella/Campylobacter infection per se.
评估年龄和合并症对老年人群人畜共患沙门氏菌和弯曲杆菌性肠胃炎的风险及预后的影响。
基于登记处的研究,纳入了1991年至2003年丹麦两个县所有首次发生的人畜共患沙门氏菌/弯曲杆菌性肠胃炎感染病例。病例为老年(≥65岁)沙门氏菌/弯曲杆菌患者。较年轻的沙门氏菌/弯曲杆菌患者以及年龄和性别匹配的个体作为对照。
共有13324例沙门氏菌/弯曲杆菌患者(包括1226例老年患者)和26648例匹配的对照。老年沙门氏菌/弯曲杆菌患者的合并症比其匹配的对照更多(比值比[95%置信区间]:1.56[1.35 - 1.80]),合并症调整后的死亡率比值(95%置信区间)在第0 - 30天、31 - 180天和181 - 365天分别为11.4(5.1 - 25.4)、1.9(1.4 - 2.6)和1.3(0.9 - 1.9)。当比较无合并症的沙门氏菌/弯曲杆菌患者和对照时,365天粗死亡率的差异随年龄增加。合并症患者中年龄的独立影响不太明确。非住院老年患者与其匹配的对照在合并症或生存率方面没有差异。
住院的老年沙门氏菌/弯曲杆菌患者的合并症和1年死亡率高于背景人群。30天额外死亡率阐明了沙门氏菌/弯曲杆菌感染本身的预后作用。